Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer.
Investigating the combination of trastuzumab and HER2/neu peptide vaccines for the treatment of breast cancer. Ann Surg Oncol. 2006 Aug; 13(8):1085-98.